These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3421975)
1. The glutathione status of rat kidney nuclei following administration of buthionine sulfoximine. Tirmenstein MA; Reed DJ Biochem Biophys Res Commun; 1988 Sep; 155(2):956-61. PubMed ID: 3421975 [TBL] [Abstract][Full Text] [Related]
2. Effect of glutathione depletion by buthionine sulfoximine on rat embryonic development in vitro. Slott VL; Hales BF Biochem Pharmacol; 1987 Mar; 36(5):683-8. PubMed ID: 2881547 [TBL] [Abstract][Full Text] [Related]
3. Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU). Kramer RA; Schuller HM; Smith AC; Boyd MR J Pharmacol Exp Ther; 1985 Aug; 234(2):498-506. PubMed ID: 4020683 [TBL] [Abstract][Full Text] [Related]
4. Marked reduction of rat brain glutathione following intracerebroventricular administration of the glutathione synthesis inhibitor L-buthionine sulfoximine. Pileblad E; Magnusson T Neurosci Lett; 1988 Dec; 95(1-3):302-6. PubMed ID: 3226616 [No Abstract] [Full Text] [Related]
5. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction. Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498 [TBL] [Abstract][Full Text] [Related]
6. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer. Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140 [TBL] [Abstract][Full Text] [Related]
7. Effect of glutathione modulation using buthionine sulfoximine on DNA methylation by dimethylnitrosamine in the rat. Tacchi AM; Jensen DE; Magee PN Biochem Pharmacol; 1987 Mar; 36(6):881-5. PubMed ID: 3566787 [TBL] [Abstract][Full Text] [Related]
8. Depletion of a discrete nuclear glutathione pool by oxidative stress, but not by buthionine sulfoximine. Correlation with enhanced alkylating agent cytotoxicity to human melanoma cells in vitro. Jevtović-Todorović V; Guenthner TM Biochem Pharmacol; 1992 Oct; 44(7):1383-93. PubMed ID: 1417960 [TBL] [Abstract][Full Text] [Related]
9. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine. Romero FJ; Sies H Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323 [TBL] [Abstract][Full Text] [Related]
10. The effect of in vivo glutathione depletion with buthionine sulfoximine on rat embryo development. Hales BF; Brown H Teratology; 1991 Sep; 44(3):251-7. PubMed ID: 1948763 [TBL] [Abstract][Full Text] [Related]
11. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice. Ishikawa M; Takayanagi Y; Sasaki K Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233 [TBL] [Abstract][Full Text] [Related]
12. Buthionine sulfoximine pretreatment potentiates the effect of isolated lung perfusion with doxorubicin. Port JL; Hochwald SN; Wang HY; Burt ME Ann Thorac Surg; 1995 Aug; 60(2):239-43; discussion 244. PubMed ID: 7544099 [TBL] [Abstract][Full Text] [Related]
13. Nuclear thiols: technical limitations on the determination of endogenous nuclear glutathione and the potential importance of sulfhydryl proteins. Loh SN; Dethlefsen LA; Newton GL; Aguilera JA; Fahey RC Radiat Res; 1990 Jan; 121(1):98-106. PubMed ID: 2300674 [TBL] [Abstract][Full Text] [Related]
14. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice. Calvin HI; Medvedovsky C; Worgul BV Science; 1986 Aug; 233(4763):553-5. PubMed ID: 3726547 [TBL] [Abstract][Full Text] [Related]
15. Role of glutathione turnover in drug sulfation: differential effects of diethylmaleate and buthionine sulfoximine on the pharmacokinetics of acetaminophen in the rat. Galinsky RE J Pharmacol Exp Ther; 1986 Jan; 236(1):133-9. PubMed ID: 3941389 [TBL] [Abstract][Full Text] [Related]
16. Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard. Somfai-Relle S; Suzukake K; Vistica BP; Vistica DT Biochem Pharmacol; 1984 Feb; 33(3):485-90. PubMed ID: 6704165 [No Abstract] [Full Text] [Related]
17. Unilateral depletion of testicular glutathione levels in the rat following intratesticular injections of diethylmaleate and buthionine sulfoximine. Slott VL; Linder RE; Strader LF; Perreault SD Toxicol Appl Pharmacol; 1989 Apr; 98(2):369-73. PubMed ID: 2711398 [TBL] [Abstract][Full Text] [Related]
18. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack. Le CT; Hollaar L; van der Valk EJ; van der Laarse A J Mol Cell Cardiol; 1993 May; 25(5):519-28. PubMed ID: 8104252 [TBL] [Abstract][Full Text] [Related]
19. Hepatocytes in primary culture become susceptible to paracetamol injury after depletion of glutathione using DL-buthionine-SR-sulphoximine (BSO). Hue DP; Griffith KL; McLean AE Biochem Pharmacol; 1985 Dec; 34(24):4341-4. PubMed ID: 4074395 [No Abstract] [Full Text] [Related]
20. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Mãrtensson J; Meister A Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4656-60. PubMed ID: 2052548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]